+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The ENHANCE study and marketing ezetimibe



The ENHANCE study and marketing ezetimibe



JAMA 299(23): 2747; Author Reply 2747-8




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056179529

Download citation: RISBibTeXText

PMID: 18560001

DOI: 10.1001/jama.299.23.2747-a


Related references

Ezetimibe, and the combination of ezetimibe/simvastatin, and risk of cancer: A post-marketing analysis. Journal of Clinical Lipidology 3(2): 138-142, 2009

Association of Prehospital Advanced Life Support by Physician With Survival After Out-of-Hospital Cardiac Arrest With Blunt Trauma Following Traffic Collisions: Japanese Registry-Based Study. JAMA Surgery 153(6): E180674, 2018

The ENHANCE Study: an unusual publication of trial data raises questions beyond ezetimibe. Expert Opinion on PharmacoTherapy 9(7): 1067-1070, 2008

Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial. American Heart Journal 149(2): 234-239, 2005

Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study. Metabolism: Clinical and Experimental 55(12): 1697-1703, 2006

Does 'ENHANCE' diminish confidence in ezetimibe?. Journal of the Association of Physicians of India 56: 665-666, 2008

Given the ENHANCE trial results, ezetimibe is still unproven. Cleveland Clinic Journal of Medicine 75(7): 497, 2008

Simvastatin with or without ezetimibe in familial hypercholesterolemia (ENHANCE). 2007

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?. New England Journal of Medicine 358(14): 1504-1507, 2008

Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010. JAMA Internal Medicine 174(9): 1486-1493, 2014

Simvastatin with or without ezetimibe in familial hypercholesterolemia (the ENHANCE trial). Current Atherosclerosis Reports 11(2): 81-82, 2009

Efficacy, safety and effect on biomarkers related to cholesterol and lipoprotein metabolism of rosuvastatin 10 or 20 mg plus ezetimibe 10 mg vs. simvastatin 40 or 80 mg plus ezetimibe 10 mg in high-risk patients: Results of the GRAVITY randomized study. Atherosclerosis 232(1): 86-93, 2014

Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada. American Heart Journal 167(5): 683-689, 2014

Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). American Journal of Cardiology 116(12): 1840-1844, 2015

Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe). Cardiovascular Therapeutics 34(5): 371-382, 2016